CD274 and neoplasm: Next, upfront or induction CTX140 1q6d therapy was employed to test whether this could stimulate an immune response by enhancing immunogenic cell death and increasing infiltration or expansion of T cells within the primary tumor, which could then be followed up with PD-L1 blockade therapy.